-
Founded in:
2011-04-11 -
Country:
China -
Address:
West side of Yanbin Road, Feixian Economic Development Zone -
Tax NO.:
913713255728813685 -
Registered Funds:
50 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cefpiramide acid |
No specific description provided
More
No specific description provided |
70797-11-4 | 9 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cefuroxime 1-acetoxyethyl ester |
This product is a second-generation cephalosporin antibiotic with a broad-spectrum antibacterial effect. Its bactericidal mechanism is to hinder the synthesis of bacterial cell walls.
More
This product is a second-generation cephalosporin antibiotic with a broad-spectrum antibacterial effect. Its bactericidal mechanism is to hinder the synthesis of bacterial cell walls. |
64544-07-6 | 17 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| guacetisal |
Extract from the above information
More
Extract from the above information |
55482-89-8 | 2 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| CeftazidiMe |
Ceftazidime is a bactericidal cephalosporin antibiotic that is resistant to most beta-lactamases and is effective against a broad spectrum of Gram-positive and Gram-negative bacteria. It works by inhibiting bacterial cell wall synthesis and is sensitive to many pathogenic strains and pathogenic strains and isolates associated with hospital-acquired infections, including strains resistant to gentamicin and other aminoglycosides. It is highly stable to the beta-lactamases produced by most clinically important Gram-positive and Gram-negative bacteria and is effective against a variety of bacteria in vitro.
More
Ceftazidime is a bactericidal cephalosporin antibiotic that is resistant to most beta-lactamases and is effective against a broad spectrum of Gram-positive and Gram-negative bacteria. It works by inhibiting bacterial cell wall synthesis and is sensitive to many pathogenic strains and pathogenic strains and isolates associated with hospital-acquired infections, including strains resistant to gentamicin and other aminoglycosides. It is highly stable to the beta-lactamases produced by most clinically important Gram-positive and Gram-negative bacteria and is effective against a variety of bacteria in vitro. |
72558-82-8 | 27 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Lansoprazole |
|
103577-45-3 | 87 |